Tranexamic acid versus placebo in individuals with intracerebral haemorrhage treated within 2 h of symptom onset (STOP-MSU): an international, double-blind, randomised, phase 2 trial

Overview of attention for article published in Lancet Neurology, April 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

news: 4 news outlets
blogs: 2 blogs
twitter: 107 X users

reddit: 1 Redditor
guideline: 2 clinical guideline sources

Readers on

mendeley: 55 Mendeley

So far, Altmetric has seen 114 X posts from 107 X users, with an upper bound of 226,317 followers.

🩸Tranexámico en pacientes con hemorragia intracraneal en las primeras 2h de síntomas: Ensayo STOP-MSU 👉 No reducción del tamaño del hematoma 👉 No mejoría de evolución clínica de los pacientes https://t.co/PAGxhHjbuB

https://t.co/2pWtn0Fvcs Yassi et al. Lancet Neurology 2024. Behind a paywall and I can't see how the study was powered. Headline results: Tranexamic Acid doesn't prevent haematoma expansion / improve functional status or mortality after ICH. But very sm…

RT @Montecoya: Tranexamic acid versus placebo in individuals with intracerebral haemorrhage treated within 2 h of symptom onset: an interna…

Tranexamic acid versus placebo in individuals with intracerebral haemorrhage treated within 2 h of symptom onset: an international, double-blind, randomised, phase 2 trial 👉🏽El crecimiento del hematoma no se reduce pese a la aplicación ultrarrápida ht…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 110 additional X posts.